A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 18, 2025

Primary Completion Date

March 18, 2028

Study Completion Date

July 18, 2028

Conditions

Advanced Solid Tumors

Interventions

DRUG

GK01 Injection

Autologous tumor-reactive T cells injection

Trial Locations (1)

RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

All Listed Sponsors

collaborator

Beijing Geek Gene Technology Co., LTD

UNKNOWN

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER